Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk.
about
Gene-Lifestyle Interactions in Complex Diseases: Design and Description of the GLACIER and VIKING StudiesVariants in blood pressure genes and the risk of renal cell carcinomaOccupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants.Epidemiology and risk factors for kidney cancer.A case-control study on the effect of Apolipoprotein E genotypes on gastric cancer risk and progressionTFE3 Translocation-Associated Renal Cell Carcinoma Presenting as Avascular Necrosis of the Femur in a 19-Year-Old Patient: Case Report and Review of the Literature.The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma.Renal cell carcinoma risk is associated with the interactions of APOE, VHL and MTHFR gene polymorphisms.Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients.Logistic Bayesian LASSO for genetic association analysis of data from complex sampling designs.Pseudo semiparametric maximum likelihood estimation exploiting gene environment independence for population-based case-control studies with complex samplesSingle nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study.Diagnostic and prognostic significance of serum apolipoprotein C-I in triple-negative breast cancer based on mass spectrometryLinking variants from genome-wide association analysis to function via transcriptional network analysis.Tumour and patient factors in renal cell carcinoma-towards personalized therapy.Secretomes are a potential source of molecular targets for cancer therapies and indicate that APOE is a candidate biomarker for lung adenocarcinoma metastasis.Expression and clinical significance of complement C3, complement C4b1 and apolipoprotein E in pancreatic cancer.
P2860
Q28397345-B8AD5E02-2964-4A4C-99B0-5BE4471CEC76Q33759665-99346A5A-BB37-480C-8AAD-13440C22ABFFQ34069062-76D79BDB-1B71-495A-ADE5-B426059FCE75Q34449963-D81A1325-D1AE-4F25-8D0D-463B5222BE89Q34457942-A62B0E3A-AC96-4AF0-B082-23D8A6B56EF8Q35293660-C899F150-8F95-4AC1-B808-2A8584C0AAEDQ35750240-1720F055-1A55-441A-A1F3-B6DF17E7A1FFQ35854397-B28800BF-DDF8-46C4-AF6D-FE58822BD68EQ36036384-3AE7DF12-8D37-4887-AD90-A4D796D1FB1BQ36351384-50C16B22-ED5A-4A89-BB9D-E8C852017C51Q36740965-CA2D7B2E-E367-42F9-A791-8E129917F0D2Q37161942-11191EF5-7DC7-422D-B6A9-182AD050BC1BQ37187745-23C5554E-2129-47D7-98CD-DEE0D9E710A9Q37720141-68205D48-810C-454C-B77F-A9F359A3DD35Q38418649-A2724886-7A64-4820-944B-73201A941BC5Q38968319-3F788132-CE26-439D-83F6-94DEEDFCEBC3Q42553545-B4513A2A-5008-4C80-8722-D660E808433D
P2860
Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk.
@en
Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk.
@nl
type
label
Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk.
@en
Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk.
@nl
prefLabel
Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk.
@en
Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk.
@nl
P2093
P2860
P50
P1433
P1476
Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk.
@en
P2093
Allison Meisner
Faith Davis
Hellena Kollarova
Joanne Colt
Kendra Schwartz
Lee E Moore
Linda M Dong
Marie Navratilova
Neonilia Szeszenia-Dabrowska
Philip S Rosenberg
P2860
P304
P356
10.1158/0008-5472.CAN-09-1734
P407
P50
P577
2009-10-06T00:00:00Z